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In this issue of Critical Care, Textoris and colleagues [1] 
report that high levels of central venous oxygen satura-
tion (ScvO2) are associated with mortality in patients 
with septic shock. ScvO2 is easily measured in most ICU 
patients and thus represents a convenient therapeutic 
marker in the resuscitation of the critically ill patient. 
Low ScvO2 is a valid therapeutic target in early septic 
shock [2,3] and a diagnostic marker for low cardiac 
output [4]. ScvO2 itself is a surrogate marker of mixed 
venous oxygen saturation, which in theory reﬂ  ects the 
balance between global oxygen delivery and consump-
tion, so that low ScvO2 is a marker of inadequate oxygen 
delivery. Still we do not fully understand the patho-
physio  logical and clinical meaning of altered ScvO2.
So far, the focus has mostly been on low levels of ScvO2, 
but Textoris and co-workers [1] have focused on higher 
levels of ScvO2 in septic shock patients. Th  ey  hypothesise 
that levels of ScvO2 above 80% correlate with increased 
mortality and that this correlation is likely due to 
impaired ability to extract oxygen. In a retrospective 
design, they identiﬁ  ed all adult ICU patients with septic 
shock in a 2-year period and registered lowest and 
highest ScvO2 measurements during the ﬁ  rst 3 days in 
the ICU. Th  ey found that the maximum ScvO2 was 
signiﬁ  cantly higher in the patients that died in hospital 
than in those who survived (85% versus 79%, P = 0.009). 
In contrast, the minimum ScvO2 did not diﬀ  er between 
these groups. Th   e association between maximum ScvO2
and mortality persisted in a multivariate analysis adjust-
ing for other variables that diﬀ  ered between the survivors 
and non-survivors.
Th  is is of obvious interest, but the study has several 
limitations, as the authors point out. Th  e retrospective 
design carries an inherent risk of selection bias since 
patients with mild disease or early death might not have 
had any ScvO2 measurements and were then excluded 
from the study. Furthermore, ScvO2 might have been 
measured more frequently in the most severely ill 
patients, increasing the chance for a high ScvO2 measure-
ment, especially as ScvO2 varies over time.
Th   e interpretation of ScvO2 remains a challenge. ScvO2
depends on arterial oxygen saturation, cardiac output, 
oxygen consumption, haemoglobin levels and shunting. 
Th   e ability of ScvO2 to reﬂ  ect systemic oxygen delivery/
consumption is not constant in time as it depends on 
many conditions, including sedation, ventilator treatment 
[5], redistribution of blood as seen in shock [6] and thus 
shock severity, the position of the catheter tip, which 
depends on the body position [7], and so on. Th  us, the 
complex mechanisms inﬂ  uencing  ScvO2 hamper the 
interpretation.
Textoris and co-workers hypothesise that the high 
ScvO2 in the non-survivor group is likely due to impaired 
oxygen extraction, but there may be other explanations. 
It is likely that very aggressive resuscitation with high 
doses of ﬂ  uid, vasopressors, inotropes and blood result-
ing in supranormal oxygen delivery, and thus high ScvO2, 
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© 2011 BioMed Central Ltdnegatively impacts on survival [8]. Alternatively, impaired 
regulation of the microcirculation might have resulted in 
shunting and thus high ScvO2. Other, un  known 
confounders may also have existed. Th  e current data 
cannot distinguish between these alternative hypo  the  ses 
as discussed by the authors.
If high ScvO2 associates with increased mortality in 
sepsis, it may have clinical implications. But the hypo-
thesis should be evaluated in a prospective, multicentre 
study with protocolized ScvO2 measurements and detailed 
registration of potentially confounding factors, including 
use of ﬂ  uid, vasopressors, inotropes and blood, to reduce 
the risk of bias. Results from such a study have the 
potential to inﬂ  uence the design of further clinical trials 
evaluating ScvO2 as a target for shock therapy.
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